Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Cash from Financing Activities (2016 - 2026)

Usana Health Sciences has reported Cash from Financing Activities over the past 16 years, most recently at -$3.6 million for Q2 2026.

  • Quarterly Cash from Financing Activities rose 74.83% to -$3.6 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was -$29.8 million through Apr 2026, down 523.45% year-over-year, with the annual reading at -$40.6 million for FY2026, 525.03% down from the prior year.
  • Cash from Financing Activities was -$3.6 million for Q2 2026 at Usana Health Sciences, down from $13.5 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $22.9 million in Q4 2024 and troughed at -$122.4 million in Q1 2022.
  • The 5-year median for Cash from Financing Activities is -$2.3 million (2023), against an average of -$11.2 million.
  • Year-over-year, Cash from Financing Activities crashed 26356.82% in 2023 and then skyrocketed 3384.8% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$150000.0 in 2022, then soared by 538.67% to $658000.0 in 2023, then skyrocketed by 3384.8% to $22.9 million in 2024, then tumbled by 104.27% to -$979000.0 in 2025, then tumbled by 271.91% to -$3.6 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Cash from Financing Activities are -$3.6 million (Q2 2026), $13.5 million (Q1 2026), and -$979000.0 (Q3 2025).